The changing epidemiology of liver disease in HIV patients

AIDS Rev. 2013 Jan-Mar;15(1):25-31.

Abstract

Liver disease continues to be one of the leading causes of hospitalization and death in HIV-infected individuals. Important etiologies include both alcoholic and non-alcoholic steatohepatitis, and coinfection with hepatitis viruses B and C. While non-alcoholic fatty liver disease is increasingly diagnosed in this population, most cases of chronic hepatitis B can be well controlled with tenofovir-based regimens, and hepatitis C has entered a revolutionary era in which most patients may be cured with direct-acting antivirals. However, important gaps remain unaddressed. Hepatitis delta is a neglected disease, despite 15 million people being infected worldwide, and represents the most severe form of viral hepatitis. Hepatitis E is largely unrecognized, despite being the major cause of acute viral hepatitis worldwide and occasionally leading to chronicity in immunosuppressed individuals.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology*
  • AIDS-Related Opportunistic Infections / immunology
  • Anti-HIV Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Coinfection
  • Disease Progression
  • End Stage Liver Disease / drug therapy
  • End Stage Liver Disease / epidemiology*
  • End Stage Liver Disease / immunology
  • Fatty Liver / drug therapy
  • Fatty Liver / epidemiology*
  • Fatty Liver / immunology
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • Hepatitis B / epidemiology
  • Hepatitis C / epidemiology
  • Hepatitis D / epidemiology
  • Hepatitis, Viral, Human / drug therapy
  • Hepatitis, Viral, Human / epidemiology*
  • Hepatitis, Viral, Human / immunology
  • Humans
  • Immunocompromised Host
  • Male

Substances

  • Anti-HIV Agents
  • Antiviral Agents